多替阿巴拉米片主治什么呢？

Suitable people are teenagers and adults over 12 years old and weighing not less than 40kg. For adults and teenagers, the recommended dosage of dolutea is one tablet each time, once a day. Adults or adolescents whose body weight is less than 40 kg should not be given dolutea as dolutea is a fixed-dose tablet and cannot be reduced. Dolutegravir is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or a dose adjustment is required, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these cases, physicians should refer to the respective product information for these medicines. Today we are going to find out what are the main treatments of Duotie Abalamid Tablets?

Launched in China on January 22, 2018, dolutea palamid tablets are suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40 kg) infected with human immunodeficiency virus (HIV). HIV-infected patients, regardless of race, should be screened for the HLA-B5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the HLA-B5701 allele, he should not take products containing abacavir. 

At present, dolutea palamid tablets have been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. Wim, head of medical affairs and vice president of GSK China/Hong Kong Dr. Swyzen, MD, said, "Through effective HIV drug treatment, the lifespans of HIV patients and healthy people are getting closer and closer. Drug compliance and convenience of medication play an increasingly important role in further improving the quality of life of patients. Currently, there is no drug that is taken once a day, one tablet at a time, on the Chinese market. The approval of Abalami Tablets fills this gap and meets the urgent need for convenient drug use by doctors and patients. "Dolute Abalami Tablets is a treatment plan with DTG, an integrase inhibitor, as the core drug, combined with two backbone drugs, abacavir and lamivudine, and is made into a single tablet for promotion, making the core drug a great improvement in HAART treatment.

The above is the content of the indications, I hope it can help you!